AMRGX
Price
$6.32
Change
-$0.37 (-5.53%)
Updated
Apr 4 closing price
Net Assets
18.02M
GFACX
Price
$53.85
Change
-$3.31 (-5.79%)
Updated
Apr 4 closing price
Net Assets
264.01B
Ad is loading...

AMRGX vs GFACX

Header iconAMRGX vs GFACX Comparison
Open Charts AMRGX vs GFACXBanner chart's image
American Growth One D
Price$6.32
Change-$0.37 (-5.53%)
VolumeN/A
Net Assets18.02M
American Funds Growth Fund of Amer C
Price$53.85
Change-$3.31 (-5.79%)
VolumeN/A
Net Assets264.01B
AMRGX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMRGX vs. GFACX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRGX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 264B vs. AMRGX (18M). AMRGX (0.00) and GFACX (0.00) have matching dividends . AMRGX was incepted earlier than GFACX: AMRGX (67 years) vs GFACX (24 years). AMRGX (4.95) is less costly to investors than GFACX (1.36). GFACX is a more actively managed with annual turnover of: 25.00 vs. AMRGX (4.00). AMRGX has a lower initial minimum investment than GFACX: AMRGX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. AMRGX (-5.31). GFACX return over 5 years is better than : 59.73 vs. AMRGX (29.85).
AMRGXGFACXAMRGX / GFACX
Total Expense Ratio4.951.36364%
Annual Report Gross Expense Ratio4.951.36364%
Fund Existence67 years24 years-
Gain YTD-4.527-5.00390%
Front Load6%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets18M264B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-5.31-1.75303%
Returns for 3 years-6.450.63-1,022%
Returns for 5 years29.8559.7350%
Returns for 10 years51.9744.46117%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences